Cargando…

Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease

Hyperuricemia relates to chronic kidney disease (CKD) progression and impaired endothelial function. Febuxostat is potent and effective for decreasing serum uric acid levels. Information for the effect of febuxostat treatment on markers of endothelial dysfunction and renal injury among patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nata, Naowanit, Ninwisut, Nanthawut, Inkong, Pitchamon, Supasyndh, Ouppatham, Satirapoj, Bancha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439119/ https://www.ncbi.nlm.nih.gov/pubmed/37596359 http://dx.doi.org/10.1038/s41598-023-40767-5

Ejemplares similares

Efficacy of Lactulose versus Senna Plus Ispaghula Husk Among Patients with Pre-Dialysis Chronic Kidney Disease and Constipation: A Randomized Controlled Trial
por: Nata, Naowanit, et al.
Publicado: (2021)

Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand
por: Nata, Naowanit, et al.
Publicado: (2020)

Efficacy of Weekly Split versus Single Doses of Ergocalciferol on Serum 25-Hydroxyvitamin D among Patients on Continuous Ambulatory Peritoneal Dialysis: A Randomized Controlled Trial
por: Nata, Naowanit, et al.
Publicado: (2021)

Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression
por: Satirapoj, Bancha, et al.
Publicado: (2018)

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease
por: Satirapoj, Bancha, et al.
Publicado: (2015)

The effect of ONCE Renal on minerals and electrolytes in predialysis patients with chronic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
por: Yongwatana, Kachonsak, et al.
Publicado: (2020)

Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study
por: Singhsakul, Amol, et al.
Publicado: (2019)

Periostin as a Tissue and Urinary Biomarker of Renal Injury in Type 2 Diabetes Mellitus
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population
por: Satirapoj, Bancha, et al.
Publicado: (2013)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2019)

Arterial Stiffness Predicts Rapid Decline in Glomerular Filtration Rate Among Patients with High Cardiovascular Risks
por: Satirapoj, Bancha, et al.
Publicado: (2020)

Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial
por: Siriwattanasit, Narongrit, et al.
Publicado: (2021)

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Nutritional status among peritoneal dialysis patients after oral supplement with ONCE dialyze formula
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study
por: Kaewput, Wisit, et al.
Publicado: (2016)

Background Activity Findings in End-Stage Renal Disease With and Without Comorbid Diabetes: An Electroencephalogram Study
por: Jatupornpoonsub, Tirapoot, et al.
Publicado: (2021)

Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression
por: Park, Seokwoo, et al.
Publicado: (2022)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Febuxostat Prevents the Cytotoxicity of Propofol in Brain Endothelial Cells
por: Hao, Jianli, et al.
Publicado: (2021)

Effects of febuxostat on renal function in patients with chronic kidney disease: A systematic review and meta-analysis
por: Lin, Tsu-Chen, et al.
Publicado: (2019)

Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease
por: Peng, Yueh-Lung, et al.
Publicado: (2020)

Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats
por: Shirakura, Takashi, et al.
Publicado: (2016)

Correction to “Febuxostat Prevents the Cytotoxicity of Propofol in Brain Endothelial Cells”
por: Hao, Jianli, et al.
Publicado: (2022)

Mulberry Leaf Reduces Oxidation and C-Reactive Protein Level in Patients with Mild Dyslipidemia
por: Aramwit, Pornanong, et al.
Publicado: (2013)

EEG Delta/Theta Ratio and Microstate Analysis Originating Novel Biomarkers for Malnutrition-Inflammation Complex Syndrome in ESRD Patients
por: Jatupornpoonsub, Tirapoot, et al.
Publicado: (2022)

QEEG characteristics associated with malnutrition-inflammation complex syndrome
por: Jatupornpoonsub, Tirapoot, et al.
Publicado: (2023)

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial
por: Trakarnvanich, Thananda, et al.
Publicado: (2021)

Comprehensive approach to diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Febuxostat Improves Uric Acid Levels and Renal Function in Patients with Chronic Kidney Disease and Hyperuricemia: A Meta-Analysis
por: Zheng, Yanqun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0b9ajol2g2ka7ipa2486kfi83e